These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

109 related items for PubMed ID: 1436233

  • 1. Phosphorus-containing metabolites in anthracycline-resistant murine leukemia P388 cells.
    Shiryaeva OA, Semenova NA, Sibeldina LA, Goncharova SA, Konovalova NP.
    Neoplasma; 1992; 39(4):229-32. PubMed ID: 1436233
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Characteristics of anthracycline-resistant strains of P388 leukemia].
    Goncharova SA, Demidova NS, Shiriaeva OA, Shevtsova VN, Konovalova NP.
    Eksp Onkol; 1987; 9(4):42-7. PubMed ID: 3678124
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Antitumor activity of idarubicin, a derivative of daunorubicin, against drug sensitive and resistant P388 leukemia.
    Tsuruo T, Oh-Hara T, Sudo Y, Naito M.
    Anticancer Res; 1993; 13(2):357-61. PubMed ID: 8517647
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Differences in daunomycin retention in sensitive and resistant P388 leukemic cells as determined by digitized video fluorescence microscopy.
    Yanovich S, Taub RN.
    Cancer Res; 1983 Sep; 43(9):4167-71. PubMed ID: 6871858
    [Abstract] [Full Text] [Related]

  • 10. Effects of tunicamycin on anthracycline resistance in P388 murine leukemia cells.
    Chou TH, Kessel D.
    Biochem Pharmacol; 1981 Nov 15; 30(22):3134-6. PubMed ID: 6950722
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Oxygen radical detoxification enzymes in doxorubicin-sensitive and -resistant P388 murine leukemia cells.
    Ramu A, Cohen L, Glaubiger D.
    Cancer Res; 1984 May 15; 44(5):1976-80. PubMed ID: 6324993
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Reversal of acquired resistance to doxorubicin in P388 murine leukemia cells by perhexiline maleate.
    Ramu A, Fuks Z, Gatt S, Glaubiger D.
    Cancer Res; 1984 Jan 15; 44(1):144-8. PubMed ID: 6690032
    [Abstract] [Full Text] [Related]

  • 15. Resistance to anthrapyrazoles and anthracyclines in multidrug-resistant P388 murine leukemia cells: reversal by calcium blockers and calmodulin antagonists.
    Klohs WD, Steinkampf RW, Havlick MJ, Jackson RC.
    Cancer Res; 1986 Sep 15; 46(9):4352-6. PubMed ID: 3460695
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Gene amplification in murine leukemia cells with multiple drug resistance acquired in vivo].
    Demidova NS, Goncharova SA, Chernova OB, Kopnin BP, Gudkov AV.
    Genetika; 1987 Oct 15; 23(10):1797-806. PubMed ID: 3692152
    [Abstract] [Full Text] [Related]

  • 19. Preparation and interaction of a low-density lipoprotein:daunomycin complex with P388 leukemic cells.
    Iwanik MJ, Shaw KV, Ledwith BJ, Yanovich S, Shaw JM.
    Cancer Res; 1984 Mar 15; 44(3):1206-15. PubMed ID: 6692404
    [Abstract] [Full Text] [Related]

  • 20. Non-antitumor vinca alkaloids reverse multidrug resistance in P388 leukemia cells in vitro.
    Inaba M, Nagashima K.
    Jpn J Cancer Res; 1986 Feb 15; 77(2):197-204. PubMed ID: 3082832
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.